Which Factors Will Push The Sepsis Diagnostics Market To Achieve $1.46 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Present And Forecasted Size Of The Sepsis Diagnostics Market?
The market size for sepsis diagnostics has seen robust growth lately. Projected growth is from $0.99 billion in 2024, increasing to $1.07 billion in 2025, with a compound annual growth rate (CAGR) of 7.8%. Factors contributing to growth in historical times include the rising occurrence of sepsis, heightened awareness about early diagnosis, an increase in healthcare spending, a rise in prevalence of hospital-borne infections, and a greater take-up of point-of-care testing.
Over the coming years, the market size for sepsis diagnostics is anticipated to experience robust growth. By 2029, it’s predicted that the market will have grown to $1.46 billion, reflecting a compound annual growth rate (CAGR) of 8.1%. This forecasted growth can be explained by factors such as the increasing demand for quick diagnosis methods, expanded investments in health infrastructure, a rising emphasis on individualized medicine, increased instances of antimicrobial resistance, and the expanding use of advanced sequencing methods. Significant trends forecasted for this period encompass the incorporation of AI in diagnostic processes, technological growth in biomarkers, progress in molecular diagnosis, a shift towards automated and digital diagnostic platforms, and the further development of artificial intelligence in diagnostics.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23514&type=smp
What Underlying Factors Are Supporting The Sepsis Diagnostics Market Growth?
An increase in the occurrence of infections gained in a hospital setting is anticipated to boost the expansion of the sepsis diagnostics market. These hospital-acquired infections (HAIs) occur during or after an individual’s admission to a health facility, usually 48 hours or more post-admission, and are not present upon admission. The rise in these instances can be attributed to growing antibiotic resistance. The heightened utilization and incorrect use of antibiotics in health institutions contribute to the emergence of antibiotic-resistant bacteria, making it tougher to handle infections. Sepsis diagnostics aid in determining these infections earlier by distinguishing pathogens and biomarkers, which facilitates prompt intervention, reducing complications. For example, data from the Australian Institute of Health and Welfare, a governmental organization in Australia, reveals in November 2024 that the occurrence of HACs was noted in 2% of public hospital admissions and 0.8% of private hospital admissions in 2022-23, with health-related infections being the most common complication. Therefore, the increased frequency of hospital-acquired infections is a key factor in boosting the sepsis diagnostics market.
How Does The Sepsis Diagnostics Market Differ By Segment?
The sepsis diagnosticsmarket covered in this report is segmented –
1) By Product: Instruments; Blood Culture Media; Assay Kits And Reagents; Software
2) By Technology: Microbiology; Molecular Diagnostics; Immunoassays; Flow Cytometry; Other Technologies
3) By Pathogen: Bacterial Sepsis; Fungal Sepsis; Viral Sepsis; Other Pathogens
4) By Method: Automated Diagnostics; Conventional Diagnostics
5) By End-Users: Hospitals And Clinics; Pathology And Reference Laboratories; Research Institutes
Subsegments:
1) By Instruments: Automated Analyzers; Point-Of-Care (PoC) Testing Devices; Microfluidic-Based Devices; Polymerase Chain Reaction (PCR) Instruments; Flow Cytometers
2) By Blood Culture Media: Aerobic Blood Culture Media; Anaerobic Blood Culture Media; Mycobacteria Blood Culture Media; Pediatric Blood Culture Media; Fungal Blood Culture Media
3) By Assay Kits And Reagents: Enzyme-Linked Immunosorbent Assay (ELISA) Kits; Polymerase Chain Reaction (PCR) Assay Kits; Immunoassay Reagents; Molecular Diagnostic Reagents; Biosensor-Based Assay Kits
4) By Software: Data Management Software; Laboratory Information Systems (LIS); Artificial Intelligence (AI)-Based Diagnostic Tools; Predictive Analytics Software; Cloud-Based Diagnostic Platforms
How Are Global Trends Impacting The Development Of The Sepsis Diagnostics Market?
Key players in the sepsis diagnostics market are concentrating their efforts on devising new and inventive solutions, including culture-free diagnostic methods, to facilitate prompt and precise sepsis identification without necessitating traditional blood cultures. These culture-free techniques seek to identify pathogens or infections with no requirement for conventional microbial culture processes. They employ state-of-the-art technologies such as polymerase chain reaction (PCR), next-generation sequencing (NGS), or immunoassays, which allow for instant pathogen identification directly from patients’ samples, such as blood, saliva, or tissues. For example, Deepull Diagnostics S.L., a manufacturer based in Spain, introduced the UllCORE diagnostic system for early detection of sepsis in April 2024. UllCORE, a benchtop, culture-free multiplex PCR platform developed by Deepull, enables accelerated identification of pathogens in sepsis and other severe infections. The system extracts microbial DNA from 8 mL of whole blood, offers 50 reportable outcomes within one hour, and can detect 95% of the pathogens that cause sepsis, including bacteria, fungi, and antibiotic resistance genes. UllCORE aims to enhance early diagnoses and curb excessive antibiotic use, thereby assisting hospitals in their fight against antimicrobial resistance.
Who Are The Global Leaders Steering The Sepsis Diagnostics Market Forward?
Major companies operating in the sepsis diagnostics market are Siemens Healthcare GmbH, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., GE Healthcare, Wolters Kluwer N.V., bioMérieux S.A., Bruker Corporation, DiaSorin S.p.A., Cepheid Inc., Seegene Inc., Luminex Corporation, T2 Biosystems Inc., Cytovale Inc., Accelerate Diagnostics Inc., Immunexpress Inc., Sepsis Alliance
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/sepsis-diagnostics-global-market-report
Which Region Is Likely To Register The Fastest Growth In The Sepsis Diagnostics Market?
North America was the largest region in the sepsis diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sepsis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=23514&type=smp
Browse Through More Reports Similar to the Global Sepsis Diagnostics Market 2025, By The Business Research Company
Diagnostic And Monitoring Ophthalmic Devices And Equipment Market 2025
Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2025
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
